Non Invasive Colon Cancer Screening Market
Non Invasive Colon Cancer Screening Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Non Invasive Colon Cancer Screening Market
Size and Growth
The Non-Invasive Colon Cancer Screening market is experiencing robust growth, driven by increasing awareness and technological advancements. The global market size is projected to reach approximately $3 billion by 2027. Key factors include rising incidence rates and demand for safer, patient-friendly screening alternatives, reshaping early detection strategies in healthcare.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Beckman Coulter, Inc.
◍ Epigenomics AG
◍ Sysmex Corporation
◍ Quest Diagnostics
◍ Exact Sciences Corporation
◍ Novigenix SA
◍ CML Healthcare, Inc.
The Non-Invasive Colon Cancer Screening Market features key players like Abbott, Beckman Coulter, Epigenomics, Sysmex, Quest Diagnostics, Exact Sciences, and Novigenix. These companies innovate diagnostic solutions, enhancing market access and awareness, driving revenue growth. Notable sales revenues include Exact Sciences at approximately $500 million and Quest Diagnostics around $3 billion.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Speciality Clinics
◍ Ambulatory Surgical Centers
◍ Diagnostic Centers
◍ Others
By Product
◍ Fecal Immunochemical Test (FIT)
◍ Guaiac-based Fecal Occult Blood Test (gFOBT)
Request Sample Report
Market Growth
Request Sample Report
$ 17.84 Billion
